TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Respiratory muscle strength - maximum expiratory pressure (MEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory muscle strength - maximum inspiratory pressure (MIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pulmonary function - forced expiratory volume in the first second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in blood pressure (systolic & diastolic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax of matrine, dictamnine, maackiain and fraxinellone in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of matrine, dictamnine, maackiain and fraxinellone in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-24 of matrine, dictamnine, maackiain and fraxinellone in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-24 of matrine, dictamnine, maackiain and fraxinellone in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motion perception performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: locomotor operation performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in non-inflammatory lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acute kidney injury prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Lowering intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lesion Contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular composite (stroke, myocardial infarction, heart failure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Podocyturia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to delivery after induction of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Gut microbiome assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sensory deficit evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Chest tube removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: concentration of AZD8566 in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and tolerability of AZD8566
Endpoint domain: Adverse events/effects
Primary endpoint: Increase number of patients with donor T-cell chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduce graft rejection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintain acute graft-vs-host disease (GVHD) incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Maintain nonrelapse mortality incidence
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients who tolerated vaccinations
Endpoint domain: Adverse events/effects
Primary endpoint: Frankfurt Complaint Questionnaire (FBF-3)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oxygen saturation during 6 minutes walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of skin lesions
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of skin lesions
Endpoint domain: Adverse events/effects
Primary endpoint: Maintenance of normal Insulin-like-Growth-Factor-1 (IGF-1) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage of subjects with laboratory-confirmed RTIs
Endpoint domain: Adverse events/effects
Primary endpoint: Trauma services recidivism
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Arrest for violent crime
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy in prevention and treatment of nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of gastric ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of All-Cancer Cases
Endpoint domain: Mortality/survival
Primary endpoint: Number of Stomach Cancer Cases
Endpoint domain: Mortality/survival
Primary endpoint: Number of Lung Cancer Cases
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants With Abnormal Hematology Values of Potential Clinical Importance (PCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change From Baseline in Mean Fasted Glucose Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants With Very Good Partial Response (VGPR) or Better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG power spectrum analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flanker test accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Congruent reaction time (Flanker test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incongruent reaction time (Flanker test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Congruent reaction time (Stroop test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incongruent reaction time (Stroop test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hyperhidrosis Disease Severity Scale (HDSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Objective gravimetric measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Quality of Life Assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Nutritional Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Analogue Pain Score (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State-trait Anxiety Inventory (STAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: American Knee Society Scores (AKS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC (Western Ontario and McMaster Universities Arthritis Index)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Days for Discontinue Assistive Devices
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Spinal excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PSS-4
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: anti-hemagglutinin (HA) antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fridericia-corrected QT ECG interval (QTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Dermatitis associated with incontinence care product
Endpoint domain: Adverse events/effects
Primary endpoint: Japanese Orthopedics Association (JOA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transient Neurological Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gas out time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from Baseline Visual analog scale (VAS) as lateral elbow pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of uncovered and/or malapposed stent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral Vasomotor Reactivity (VMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Platelet Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of grade II-IV acute graft-versus host disease
Endpoint domain: Adverse events/effects
Primary endpoint: Immune responses to components of SARS-Cov-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Swabs for the presence of SARSCoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Manual Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in post-traumatic growth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Patient-assessed Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in sedentary time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Wound complication
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Children With Documented Risk Factors for Type 2 Diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: prevalence of non-users of street opioid
Endpoint domain: Mortality/survival
Primary endpoint: guideline adherence
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Toxicity associated with whole brain irradiation
Endpoint domain: Adverse events/effects
Primary endpoint: ESBL carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Higher order corneal aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oscillatory brain activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical Outcome of Cure at Test of Cure (TOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in the total reflux symptom index (RSI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elevated CIMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correlation between Hum Test and Audiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Correlation between Hum Test and Weber Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in Schirmer's Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants That Met Sustained Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of visual read of AV-133 PET scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of visual read of AV-133 PET scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unacceptable Toxicity Status
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Without Disease Progression
Endpoint domain: Mortality/survival
Primary endpoint: Fat and fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Respiratory dynamic parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in self-reported stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Muscle/tendon morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fiber area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal score of vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects or Incidence with Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: EEG Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in GERD-HRQL Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with serious complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in total distal acid exposure
Endpoint domain: Physiological/clinical
Primary endpoint: Prevalence of recurrent goiter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidental thyroid cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Need for revision thyroid surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lip Fullness Grading Scale (LFGS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of infiltrating CD3+ T cells/μm2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Activated T-cell concentration (SUVmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of xerostomia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in HAM-D Score From Baseline to Week 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CDRS-R Score From Baseline to Week 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy in treating respiratory depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of patients with xerostomia of grade 2 or worse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implant body stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: development or increase level of anti-nuclear antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: development or increase level of anti-cyclic citrullinated peptide antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: development or increase level of rheumatoid factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: development or increase level of Anti-glutamic acid decarboxylase antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: development or increase level of Anti-thyroperoxydase antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Accuracy of transient elastography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain during mandibular movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum interincisor opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary Closure Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Trips to the Operating Room
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Operating Room Time Utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time from second agent induction to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hb measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: measure of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to biochemical recurrence (BCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Difference in pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macular pigment density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite characteristics of brain oscillations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: re-intubation rate within 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change on vascular inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Ischemic Stroke
Endpoint domain: Mortality/survival
Primary endpoint: Transient ischemic attack (TIA)
Endpoint domain: Mortality/survival
Primary endpoint: Incremental shuttle walk performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial function as measured by reactive hyperemia EndoPAT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average Daily Frequency of Regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Weight-for-Age Z-Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I-GERQ-R Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of sustained HBsAg negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Viral response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Mean daily step count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve from zero to 24 hours at steady-state of ezogabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: calcium isotope ratio δ44/40Ca in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in National Institutes of Health Stroke Scale (NIHSS score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Rivermead mobility index (RMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined MACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum total 25-hydroxyvitamin D (25(OH)D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Global incidence of SARS-CoV-2 infections
Endpoint domain: Mortality/survival
Primary endpoint: number of in-hospital death
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of 12-lead electrocardiogram (ECG) abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: maximum plasma concentration (Cmax) for olorofim
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve to time of last quantifiable concentration (AUC0-tlast) for olorofim
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post procedural awakening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (conjunctival symptoms)
Endpoint domain: Adverse events/effects
Primary endpoint: Carotid artery stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Classified as Responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hours before deemed fit for discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Medication adherence
Endpoint domain: Resource use
Primary endpoint: Behavioral Responses
Endpoint domain: Life impact
Primary endpoint: Comprehension of educational document
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of Subjects With hSBA Seroresponse Against Serogroups A, C, W and Y
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Subjects With At Least One Severe Systemic Reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Change in Non-High Density Lipoprotein Cholesterol (Non-HDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fugl Meyer Assessment Upper Limb (FMA-UL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complication rates associated with bone marrow biopsy
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of bone marrow biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of CD markers in immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of post operative adverse events/effects
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Time for T-shirt Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Time for Transfer Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sitting Balance Performance Protocol, 4-way Reach Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Force from Trunk Strength Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in carotid-radial pulse wave velocity (cr-PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Palatability of defined foods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma GDF15 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes